SydPath teams up with Mayo Clinic to expand services You are here:HomeNewsroomNews SydPath teams up with Mayo Clinic to expand services 13 Dec 2023 SydPath St Vincent’s Hospital Sydney, selects Mayo Clinic Laboratories to expand access to specialised neurology and haematology reference laboratory testing services across Australia. A fully accredited NATA, RCPA and TGA registered laboratory offering a wide range of pathology services, SydPath is located within the St Vincent’s Hospital Campus, and is part of St Vincent’s Health Australia, the nation’s largest not-for-profit health and aged care provider. Extensive experience at the forefront of diagnostic pathology and ongoing commitment to research and scientific development enables SydPath to provide a service based on the most recent advances in scientific pathology and laboratory technology using testing offered by Mayo Clinic Laboratories will extend our premium services even further. Mayo Clinic Laboratories is a global reference laboratory that helps healthcare providers worldwide advance their patient care, strengthen practices and broaden access to specialised testing. By selecting Mayo Clinic Laboratories as its reference laboratory, SydPath aims to provide expanded specialised neurology and haematology testing services, and access to the clinical expertise of Mayo Clinic Laboratories to deliver optimised actionable results for doctors and patients. Autoimmune neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Mayo Clinic’s Neuroimmunology Laboratory has developed a unique approach to complement clinical acumen and improve patient care. SydPath Medical Director, Professor John (Jock) Harkness said “SydPath welcomes the opportunity to work with Mayo Clinic Laboratories to increase access to specialised testing for our clinicians and their patients. The introduction of these expanded reference laboratory testing capabilities will provide additional tools for clinicians to enable answers to the rarest and most complex neurological autoimmune and haematological conditions. Offering a wider range of pathology tests and expanding access to expertise firms our commitment to continuously grow our clinical capabilities and positively impact more patients’ lives and their health outcomes.” For more information, please contact: Michelle Blackwell Ph: +61 478 260 610 E: michelle.blackwell@svha.org.au